Ronald Drengler

机构：South Texas Accelerated Research Therapeutics

发表论文 66 篇 · 总被引 1709 次 · h-index 15

代表论文

• Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors (2015 · Clinical Cancer Research · 被引 800)
• Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma (2024 · The Oncologist · 被引 40)
• Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma (2026 · Clinical Cancer Research · 被引 6)
• Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancers (2026 · Cancer · 被引 4)
• Abstract P3-08-05: Correlation of Trop2 expression with in vivo sensitivity to sacituzumab govitecan in a panel of breast XPDX models (2023 · Cancer Research · 被引 1)
• Increasing the anemia panel rate for cancer-induced anemia (CIA) in patients at a community cancer care clinic: A quality improvement project. (2025 · JCO Oncology Practice)